MRI-targeted prostate biopsy: the next step forward!
Authors:
Open Access
- 27 November 2020
- journal article
- review article
- Published by Clujul Medical in Medicine and Pharmacy Reports
- Vol. 94 (2) , 145-157
Abstract
Aim. For decades, the gold standard technique for diagnosing prostate cancer was the 10 to 12 core systematic transrectal or transperineal biopsy, under ultrasound guidance. Over the past years, an increased rate of false negative results and detection of clinically insignificant prostate cancer has been noted, resulting into overdiagnosis and overtreatment. The purpose of the current study was to evaluate the changes in diagnosis and management of prostate cancer brought by MRI-targeted prostate biopsy. Methods. A critical review of literature was carried out using the Medline database through a PubMed search, 37 studies meeting the inclusion criteria: prospective studies published in the past 8 years with at least 100 patients per study, which used multiparametric magnetic resonance imaging as guidance for targeted biopsies. Results. In-Bore MRI targeted biopsy and Fusion targeted biopsy outperform standard systematic biopsy both in terms of overall and clinically significant prostate cancer detection, and ensure a lower detection rate of insignificant prostate cancer, with fewer cores needed. In-Bore MRI targeted biopsy performs better than Fusion biopsy especially in cases of apical lesions. Conclusion. Targeted biopsy is an emerging and developing technique which offers the needed improvements in diagnosing clinically significant prostate cancer and lowers the incidence of insignificant ones, providing a more accurate selection of the patients for active surveillance and focal therapies.Keywords
This publication has 73 references indexed in Scilit:
- Detection of the index tumour and tumour volume in prostate cancer using T 2‐weighted and diffusion‐weighted magnetic resonance imaging ( MRI ) aloneBJU International, 2014
- A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS TrialEuropean Urology, 2014
- Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic ReviewEuropean Urology, 2014
- Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific AntigenEuropean Urology, 2014
- Multiparametric magnetic resonance imaging ( MRI ) and subsequent MRI /ultrasonography fusion‐guided biopsy increase the detection of anteriorly located prostate cancersBJU International, 2014
- Critical Evaluation of Magnetic Resonance Imaging Targeted, Transrectal Ultrasound Guided Transperineal Fusion Biopsy for Detection of Prostate CancerJournal of Urology, 2013
- 2D-3D rigid registration to compensate for prostate motion during 3D TRUS-guided biopsyMedical Physics, 2013
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary GradesEuropean Urology, 2012
- Detection of Prostate Cancer via Biopsy in the Medicare-SEER Population During the PSA EraJNCI: Journal of the National Cancer Institute, 2007
- Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy FindingsJournal of Urology, 2006